US Food and Drug Administration (FDA) has approved Reckitt Benckiser Pharmaceuticals's Suboxone (buprenorphine and naloxone) sublingual film 4 mg and 12 mg doses. Suboxone is an office-based treatment used to treat opioid dependence, ...
Tags: Suboxone Tablets, office-based treatment, opioid dependence
US-based Cornerstone Therapeutics has entered into an agreement to acquire the US marketing rights to Chiesi Farmaceutici's BETHKIS (Tobramycin Inhalation Solution), designed for the treatment of cystic fibrosis patients with Pseudomonas ...
Tags: US-based Cornerstone Therapeutics, Chiesi Farmaceutici's BETHKIS
Catalent Pharma Solutions has signed a supply agreement with Vivus to supply Qsymia capsules, a proprietary combination phentermine and extended-release topiramate. Catalent Modified Release Technologies president Ian Muir said Catalent ...
Tags: Qsymia capsules, extended-release topiramate, combination therapy
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC) siRNA delivery system. The patent application No.13/032,029 covers claims for ...
Tags: siRNA delivery system, US Patent, dynamic polyconjugate, DPC platform
Baxter International has gained approval for ADVATE [Recombinant Human Coagulation Factor VIII for injection] to treat hemophilia A in China. ADVATE is infused directly into the bloodstream, allowing the body's blood clotting process to ...
Tags: Baxter International, ADVATE, hemophilia A, bleeding episodes
INJEX Pharma and American Healthcare Products have signed an exclusive distribution agreement to market needle-free syringe Injex 30 in the west coast states of US. According to the agreement, American Healthcare Products will distribute ...
Tags: INJEX Pharma, American Healthcare Products, syringe Injex 30
BioDelivery Sciences International, a developer of drug delivery technologies, and Endo Health Solutions have started enrolling patients for its Phase 3 clinical program of BEMA Buprenorphine, designed as a treatment for moderate to severe ...
Tags: BioDelivery Sciences International, Endo Health Solutions
Cardiovascular Systems has completed enrolling 443 patients in the ORBIT II trial of its electric orbital atherectomy system(OAS),designed to treat severe calcified coronary arteries. The first premarket approval(PMA)trial,which is ...
Tags: cardiovascular system, OAS, severe calcified coronary arteries, ORBIT II
Wockhardt has received final approval from the US Food and Drug Administration ((FDA) to market extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used to treat hypertension. Felodipine is the generic name for ...
GI medical devices developer Given Imaging has submitted an application to US Food and Drug Administration(FDA)seeking approval to use its non-invasive imaging tool for visualization of the lower gastrointestinal tract. The PillCam Colon ...
Tags: PillCam Colon 2 capsule endoscopy system, Given Imaging
ChiRhoClin has relaunched an orphan drug product,ChiRhoStim(Human Secretin for Injection)used to diagnose pancreatic cancer and pancreatic exocrine dysfunction. The company has received permission to market the current batch of ...
Tags: ChiRhoClin, Chirhostim Drug, orphan drug product, pancreatic cancer
Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bladder (OAB). The product is available in a metered pump dispenser and is delivered transdermally, resulting in a ...
Albany Molecular Research (AMRI) has reported a net loss of $2.14m, or $0.07 per share, for the third quarter ended 30 September 2012 compared to a net loss of $5.85m, or $0.19 per share, for the third quarter ended 30 September 2011. ...
Wockhardt, a pharmaceutical and biotechnology company, has received final FDA approval for marketing 100mg, 150mg and 200mg 12 hour extended release tablets of Bupropion HCl indicated for depression. Wockhardt has announced the immediate ...
Hospira has entered into a definitive agreement to purchase Orchid Chemicals&Pharmaceuticals'FDA-approved active pharmaceutical ingredient(API)manufacturing and Chennai-based R&D facilities for approximately$200m. The acquisition will ...
Tags: Orchid Chemicals, Hospira, active pharmaceutical ingredient